Cryptopolitan on MSN
This promising anti-aging drugs just failed its human test
One of the most studied lifespan-extending drugs in animals has just failed its test on humans in a 13-week clinical trial co ...
In 2026, Trimology has quickly become one of the most searched weight loss supplements for women over 35, yet with ...
GLP-1 generics enter the world’s diabetes capital and are added to bridal packages to cut ‘food noise’; can they fix India's ...
From lifestyle habits to emotional support, the absence of marriage or a partner may quietly influence cancer risk in ways we’re only beginning to understand.
AVAI, BIOA, NAGE, LLY, and NVO Lead a New Wave of Metabolic and Molecular Anti-Aging Therapies Issued on behalf of Avaí Bio, Inc. Companies mentioned in this article: Avaí Bio, Inc. (OTCQB: AVAI), ...
Bicycling on MSN
The real benefit of riding indoors? Better rides outside
It’s not just about chasing watts. A pioneering Zwift coach explains how trainer time helps cyclists clean up their form, ...
If you’re one of those people who plan to live forever and you happen to be in London over the next few months, you might ...
Want an Easy Way to Keep Your Pills Organized? Here Are the 9 Best Pillboxes We Tested and Recommend
Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...
The FDA approved a GLP-1 pill from Eli Lilly called Foundayo. Foundayo isn't as effective as Lilly's weekly shot Zepbound, but the once-daily pill could be attractive for people looking for ...
Eli Lilly & Co.’s weight-loss pill won US approval, ratcheting up pressure on Novo Nordisk A/S, which launched an obesity pill earlier this year. Lilly’s once-daily pill, called Foundayo, was approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results